ArticlePloS one2025
The prognostic value of the direct bilirubin to albumin ratio in critically ill patients with cirrhosis: Insights from MIMIC-IV database.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prognostic Value of the Total Bilirubin-to-Albumin Ratio in Critically Ill Patients with Gastrointestinal Bleeding: A Multicentre Cohort Study.Emergency medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with severe cirrhosis are at a higher risk of mortality. This study aimed to investigate the association between the direct bilirubin-to-albumin ratio (DBAR) and 28-day mortality in critically ill cirrhotic patients using data from the publicly available MIMIC-IV database.
methodsThis study explores DBAR's relationship with 28-day mortality in severe cirrhosis patients. We first conducted univariate and multivariate analyses to identify independent risk factors. Then, we used Kaplan-Meier (KM) survival analysis to assess DBAR's link with survival time and created KM curves. DBAR's predictive accuracy was evaluated using Receiver Operating Characteristic (ROC) analysis, and the relationship was examined using restricted cubic spline modeling and subgroup analyses.
resultThis study enrolled 509 cirrhotic patients with in-hospital and ICU mortality rates of 22.3% and 14.3%, respectively. Univariate and multivariate analyses revealed a significant association between DBAR and 28-day mortality risk, with a hazard ratio of 1.16 (95% CI: 1.10-1.24, p < 0.001), confirming DBAR as an independent risk factor for short-term prognosis. DBAR demonstrated good predictive accuracy for 28-day mortality (AUC = 0.702, 95% CI: 0.650-0.753). Patients were divided into low-risk (DBAR < 4) and high-risk (DBAR ≥ 4) groups, with the high-risk group showing a hazard ratio of 3.05 (95% CI 1.87-4.97, p < 0.001) after multivariate adjustment. Restricted cubic spline (RCS) analysis identified a nonlinear relationship between DBAR and 28-day prognosis (p-Nonlinear = 0.022, p < 0.001). Subgroup analysis showed no interaction between DBAR and most subgroups.
conclusionThe DBAR scoring system offers an efficient and user-friendly approach for assessing prognosis in critically ill cirrhotic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.